34 phenotypes from 1 allele in 2 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Rgntm1Aish/Y involves: 129P2/OlaHsd	abnormal amino acid level	J:108295
	abnormal brain morphology	J:107922
	abnormal circulating amino acid level	J:108295
	abnormal enzyme/coenzyme activity	J:108295
	abnormal gait	J:108295
	abnormal hair cycle	J:150664
	abnormal hepatocyte mitochondrial morphology	J:88791
	abnormal hepatocyte morphology	J:88791
	abnormal keratinocyte morphology	J:150664
	abnormal liver vasculature morphology	J:88791
	abnormal phospholipid level	J:88791
	abnormal pulmonary acinus morphology	J:101810, J:135721
	abnormal vitamin C level	J:108295, J:150664
	decreased body weight	J:88791
	decreased bone mineral density	J:108295
	decreased hydroxyproline level	J:150664
	decreased percent body fat/body weight	J:108295
	emphysema	J:135721
	femur fracture	J:108295
	hepatic steatosis	J:88791
	increased cellular sensitivity to oxidative stress	J:135721
	increased liver cholesterol level	J:88791
	increased liver triglyceride level	J:88791
	increased susceptibility to induced morbidity/mortality	J:108295
	oxidative stress	J:107922, J:135721
	premature death	J:88791
	rachitic rosary	J:108295
	thin dermal layer	J:150664
	weight loss	J:108295, J:135721
Rgntm1Aish/Y involves: 129P2/OlaHsd * C57BL/6	abnormal vitamin C level	J:155625, J:191530
	alopecia	J:155625
	anterior subcapsular cataract	J:191530
	cochlear ganglion degeneration	J:155625
	increased or absent threshold for auditory brainstem response	J:155625
Rgntm1Aish/Rgntm1Aish involves: 129P2/OlaHsd * C57BL/6	abnormal vitamin C level	J:191530
	anterior subcapsular cataract	J:191530
	increased hepatocyte apoptosis	J:79342